NewsView printer-friendly version
Coherus BioSciences to Report Fourth Quarter and Full Year 2020 Financial Results on February 24th
Conference Call Information
Dial-in: (844) 452-6826 (toll free) or (765) 507-2587 (International)
Conference ID: 3770488
Please join the conference call at least 10 minutes early to register. The webcast will be archived on the Coherus website.
Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system.
For additional information, please visit www.coherus.com.
EVP, Financial Strategy and IR
+1 (650) 395-0152
Source: Coherus BioSciences, Inc.